Answers are grounded in this paper and cite their sources.
FDA and EMA guidelinesBioanalytical method validation employed for the quantitative determination of drugs and their metabolites in biological fluids plays a significant role in the evaluation and interpretation of bioavailability, bioequivalence, pharmacokinetic, and toxicokinetic study data [2].These studies generally support regulatory filings [3].The quality of these studies is directly related to the quality of the underlying bioanalytical data.It is therefore important that guiding principles for the validation of these analytical methods be established and disseminated to the pharmaceutical community.
No takes yet. Share an insight, caveat, or question.
Lalit Vijay Sonawane (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: